Oxidative Stress and Antioxidant Status in High-Risk Prostate Cancer Subjects.

The oxidant/antioxidant balance has been implicated in the pathophysiology of prostate cancer. We investigated oxidative damage and antioxidant status in high-risk prostate cancer subjects. Reduced glutathione (GSH) levels were measured in erythrocytes, 8-hydroxydeoxyguanosine (8-OHdG) in leukocytes and plasma levels of catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (GSH-R), glutathione S-transferase (GST), superoxide dismutase (SOD), and lipid peroxide products were measured in high-risk and age-matched healthy subjects. Serum PSA levels were significantly higher ( < 0.0001) in high-risk subjects, whereas GST ( < 0.0001) and GSH ( < 0.002) were higher in healthy controls. Levels of 8-OHdG, an oxidized nucleoside of DNA, were significantly increased ( < 0.0001) in high-risk subjects. No marked difference in the levels of CAT ( = 0.237), GSH-Px ( = 0.74), GSH-R ( = 0.344), SOD ( = 0.109), and lipid peroxide products ( = 0129) were observed between two groups. Pearson's correlation between GST and PSA (r = -0.69 ( < 0.0001)), GST and 8-OHdG (r = -0.62 ( < 0.0004)), GSH and 8-OHdG (r= -0.39 ( = 0.038)), and CAT and GSH-Px (r= -0.33 ( = 0.04)) were found to be negatively correlated, whereas 8-OHdG and PSA were positively associated (r= 0.57 ( < 0.002). These results indicate a significant role of oxidative damage in prostate carcinogenesis, particularly during the early stages of development. In conclusion, our data support the importance of antioxidant defense as a valuable diagnostic and/or prognostic marker in prostate cancer.